"These drugs are so expensive -- $14,000-$15,000 a year. Cardiologists have never been faced with a situation like this," said DeMaria, who noted that the prices quoted for the PCSK9 drugs were similar to the costs of cancer drugs but with an important difference: "these drugs are forever. Forever."
What I Learned in Washington DC
Il y a 7 heures